Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide

Allogeneic stem cell transplant can have high morbidity and mortality in patients with myelofibrosis (MF) and multiple myeloma (MM). This phase 2 study used a novel myeloablative regimen of split-dose busulfan, fludarabine, and then post-transplant cyclophosphamide. Four patients with MF and 2 with...

Descripción completa

Detalles Bibliográficos
Autores principales: Trunk, Andrew D., Patel, Sagar S., Prchal, Josef T., Sborov, Douglas W., Zander, Axel R., Lee, Catherine J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493243/
https://www.ncbi.nlm.nih.gov/pubmed/37701906
http://dx.doi.org/10.1016/j.lrr.2023.100388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493243/
https://www.ncbi.nlm.nih.gov/pubmed/37701906
http://dx.doi.org/10.1016/j.lrr.2023.100388

Ejemplares similares